Clinical trial
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial With Stent Evaluation in All-comers IV (TWENTE IV)
NCT02508714 is registered in ClinicalTrials.gov with Thorax Centrum Twente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents (BIONYX): A Randomized Trial With Stent Evaluation in All-comers IV (TWENTE IV)
- Lead sponsor
- Thorax Centrum Twente
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 7, 2016
- Completion date
- March 31, 2019
- Enrollment
- 2,470 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, angina pectoris, coronary artery disease, coronary restenosis, coronary stenosis, unstable angina pectoris